Any patient suffering from new or worsening medical symptoms hopes for a relatively quick and accurate diagnosis.

Lupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital orga ...

Lupus can do irreversible harm to a person's organs, damaging the lungs, kidneys, heart, liver and other vital organs through ...

For patients with moderately to severely active systemic lupus erythematosus (SLE), anifrolumab is associated with l ...

New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people in the United States ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

New Study Shows Certain Combinations of Antiviral Proteins Are Responsible for Lupus Symptoms and Affect Treatment Outcomes May 13, 2024 — Researchers say they have uncovered insights as to why ...

Obinutuzumab B-cell depleting therapy is more effective than standard care in treating patients with active proliferative lupus nephritis.

Every time you get sick, your body keeps a record of it. It does so through your immune system, a vast army of cells that mobilizes to fight off diseases. And after the infection is over — if it’s ...

However, a newer lupus drug, anifrolumab (brand name Saphnelo), has shown promising results in reducing organ damage, ...

Recent decades have witnessed remarkable strides in the realm of clinical research and treatment for Systemic Lupus Erythematosus (SLE) and Sjögren’s ...